1-5 of 5
Authors: Ruben Coronel
Sort by
Journal Article
Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
Talip E Eroglu and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 4, July 2024, Pages 289–295, https://doi.org/10.1093/ehjcvp/pvae022
Published: 22 March 2024
Journal Article
Use of proton pump inhibitors is associated with increased risk of out-of-hospital cardiac arrest in the general population: a nested case-control study
Talip E Eroglu and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 5, August 2024, Pages 413–419, https://doi.org/10.1093/ehjcvp/pvae020
Published: 14 March 2024
Journal Article
Sodium-glucose cotransporter-2 inhibitors compared with glucagon-like-peptide-1 receptor agonists and out-of-hospital cardiac arrest in type 2 diabetes: a nationwide nested case-control study
Yrsa Kolka Júlíusdóttir and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 437–443, https://doi.org/10.1093/ehjcvp/pvad033
Published: 12 May 2023
Journal Article
Use of methylphenidate is associated with increased risk of out-of-hospital cardiac arrest in the general population: a nationwide nested case-control study
Talip E Eroglu and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 7, November 2023, Pages 658–665, https://doi.org/10.1093/ehjcvp/pvad028
Published: 17 April 2023
Journal Article
Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus
Talip E Eroglu and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 1, January 2023, Pages 18–25, https://doi.org/10.1093/ehjcvp/pvac043
Published: 27 July 2022
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals